From: Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung
Case No. | Pathology | Sampling procedure | Intensity score | Proportion score | Total IHCscore | Expressionof PCT | Serum PCT (ng/mL) | Serum CRP (mg/dL) | Metastasis |
---|---|---|---|---|---|---|---|---|---|
1 | LCNEC | Surgery | 1 | 0 | 1 | Low | 0.05 | 4.17 | – |
2 | LCNEC | Surgery | 2 | 1 | 3 | High | 0.07 | 0.08 | Br |
3 | LCNEC | Surgery | 0 | 0 | 0 | - | 0.08 | 1.16 | – |
4 | LCNEC | Surgery | 0 | 0 | 0 | - | N/D |  < 0.02 | – |
5 | LCNEC | Surgery | 0 | 0 | 0 | - | 0.14 | 11.20 | – |
6 | LCNEC | Surgery | 0 | 0 | 0 | - | 0.03 | 0.04 | – |
7 | LCNEC | Surgery | 2 | 4 | 6 | High | 170.4 | 2.05 | Br, Ad |
8 | LCNEC | Surgery | 0 | 0 | 0 | - | 0.06 | 6.00 | - |
9 | LCNEC | Surgery | 2 | 4 | 6 | High | 16.72 | 1.90 | Br, Bo, Pl |
10 | LCNEC | Surgery | 1 | 0 | 1 | Low | 0.03 | 0.07 | – |
11 | Carcinoid | Surgery | 2 | 4 | 6 | High | 0.35 | 19.26 | – |
12 | Carcinoid | Surgery | 0 | 0 | 0 | - | N/E | 0.09 | – |
13 | Carcinoid | Surgery | 2 | 0 | 2 | Low | 0.03 |  < 0.02 | – |
14 | Carcinoid | Surgery | 0 | 0 | 0 | - | N/E |  < 0.02 | – |
15 | SCLC | Surgery | 0 | 0 | 0 | - | 0.07 | 2.80 | – |
16 | SCLC | Bronchoscopy | 0 | 0 | 0 | - | 0.24 | 2.89 | – |
17 | SCLC | Bronchoscopy | 0 | 0 | 0 | - | 0.03 | 0.06 | – |
18 | SCLC | Bronchoscopy | 0 | 0 | 0 | - | 0.07 | 3.04 | – |
19 | SCLC | Bronchoscopy | 0 | 0 | 0 | - | 0.04 | 3.05 | – |
20 | SCLC | Bronchoscopy | 0 | 0 | 0 | - | 0.05 | 0.04 | – |
21 | SCLC | Bronchoscopy | 0 | 0 | 0 | - | N/D | 0.09 | Br |